Bloom Marlene Z
Consult Pharm. 2012 Dec;27(12):844-7. doi: 10.4140/TCP.n.2012.844.
There are very few pharmacists who were there when modern day consultant pharmacy was formed, but Samuel W. Kidder, PharmD, MPH, who died October 14, 2012, at the age of 76, was one of them. As a government regulator, he helped create the role of the consultant pharmacist by developing regulations for drug regimen review and standards for detecting medication errors. Because of Kidder's ongoing involvement in nursing facility survey and certification, he also was a key resource for ASCP. He was a strong supporter of consultant pharmacists and championed reimbursement for their services. Considered a visionary in the field, he was known as an advocate both for pharmacists and for patients.
在现代咨询药学形成之时,在世的药剂师寥寥无几,但塞缪尔·W·基德博士(Samuel W. Kidder, PharmD, MPH)是其中之一,他于2012年10月14日去世,享年76岁。作为一名政府监管人员,他通过制定药物治疗方案审查法规和药物错误检测标准,帮助确立了咨询药剂师的角色。由于基德持续参与护理机构的调查和认证工作,他也是美国顾问药师协会(ASCP)的重要信息来源。他是咨询药剂师的坚定支持者,主张为他们的服务提供报销。在该领域,他被视为有远见卓识的人,以维护药剂师和患者的权益而闻名。